QT Imaging Holdings, Inc. (Nasdaq:
QTI) announced on March 24, 2026, that its Breast Acoustic CT™ scanner received official classification and clearance from the UAE Emirates Drug Establishment (EDE).
This clearance enables importation, distribution through EDE-licensed warehouses, and marketing to healthcare facilities in the UAE.
Supports commercial deployment under an exclusive January 2026 distribution agreement with Al Naghi Medical Co., creating a $24 million revenue pipeline through 2028.
Breast cancer represents 25% of all cancers and 43% of women's cancers in the UAE, highlighting need for safe imaging solutions.
Expands QT Imaging's presence in the Middle East, complementing its Saudi Arabia agreement with Gulf Medical.
Quote from Chief Commercial Officer Satrajit Misra:
UAE clearance is a pivotal milestone for global commercial presence.